Actively Recruiting
Safe Zone in Trigger Point Injection
Led by Ankara University · Updated on 2024-10-29
211
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to define the safe distance that will reduce the risk of pneumothorax through ultrasonographic imaging measurements in both sitting and prone positions to ensure patient safety during these procedures. The main question\[s\] it aims to answer \[is/are\]: The mean distance between the skin and pleura in sitting position during the inhalation and exhalation The mean distance between the skin and pleura in prone position during the inhalation and exhalation
CONDITIONS
Official Title
Safe Zone in Trigger Point Injection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Myofascial Pain Syndrome
- Patients scheduled for trigger point injections due to Myofascial Pain Syndrome
You will not qualify if you...
- Under 18 years of age
- Having additional diseases other than Myofascial Pain Syndrome
- Presence of active infection in the interscapular area where ultrasound imaging and measurements will be performed
- Lesions that disrupt skin integrity or affect subcutaneous and muscle structures such as anomalies or masses impairing imaging quality
- Known lung diseases
- Not consenting to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara University Department of Anesthesiology and Reanimation
Ankara, Turkey (Türkiye), 06230
Actively Recruiting
Research Team
S
Süheyla Karadağ Erkoç, MD
CONTACT
B
Büşra Şahin Kıdam, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here